Hypercholesterolemia, Familial Clinical Trial
Official title:
A Kinetic Study Investigating Lipoprotein Metabolism Before and After the Administration of REGN1500, an ANGPTL3 Inhibitor, in Patients With Homozygous Familial Hypercholesterolemia. A Sub-study for Subjects Enrolled in the R1500-CL-1331 Clinical Trial
To evaluate the lipoprotein kinetics of subjects enrolled in the R1500-CL-1331 clinical trial (NCT02265952) to assess the mechanism by which the evinacumab may affect lipid levels in HoFH subjects.
Subjects enrolled in the R1500-CL-1331 clinical trial (NCT0226595) will participate in a study visit before and after administration of the ANGPTL3 inhibitor REGN1500, evinacumab) for the evaluation of its effect on lipoprotein kinetics. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00384293 -
Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)
|
Phase 3 | |
Completed |
NCT04118348 -
Evaluating the Efficacy of Pediatric Lipid Screening Alerts
|
N/A | |
Completed |
NCT00000594 -
NHLBI Type II Coronary Intervention Study
|
Phase 3 | |
Completed |
NCT04526457 -
Is Family Screening Improved by Genetic Testing of Familial Hypercholesterolemia
|
N/A | |
Completed |
NCT01753232 -
Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter
|
N/A | |
Completed |
NCT03018678 -
Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia
|
||
Completed |
NCT00134511 -
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder
|
Phase 3 | |
Completed |
NCT00134485 -
Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia
|
Phase 3 | |
Recruiting |
NCT04073797 -
PET Imaging of Inflammation and Lipid Lowering Study
|
N/A | |
Terminated |
NCT01583647 -
A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158)
|
Phase 1 | |
Completed |
NCT00515307 -
Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia
|
Phase 1 | |
Recruiting |
NCT04656028 -
Genetic Testing and Motivational Counseling for FH
|
N/A | |
Terminated |
NCT00092833 -
Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)
|
Phase 3 | |
Active, not recruiting |
NCT04837638 -
Diet Quality and Coronary Artery Calcification in Adults With Heterozygous Familial Hypercholesterolemia
|
||
Completed |
NCT00280995 -
Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy
|
Phase 2 | |
Completed |
NCT06231459 -
Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia
|
Phase 4 | |
Completed |
NCT01524289 -
Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)
|
Phase 3 | |
Completed |
NCT00281008 -
Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy
|
Phase 2 | |
Recruiting |
NCT03989167 -
Clinical Decision Support for Familial Hypercholesterolemia
|
N/A | |
Completed |
NCT03795038 -
Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI
|
N/A |